32P Discovering markers that identify pro-metastatic immune cell subsets

Due to lack of reliable markers that determine metastatic potential and guide cancer treatment; metastasis remains a major cause of cancer-related deaths. Immune cells, especially myeloid cells, contribute significantly to metastasis and could function as potential prognostic markers. However, due to their tremendous heterogeneity and plasticity; no reliable and clinically translatable markers to define pro-metastatic immune cell subsets have been identified. With this study we aim to gain deeper insights into myeloid immune cell activities in metastatic tumors to reveal potential markers that define pro-metastatic immune cells.